https://www.selleckchem.com/pr....oducts/1-deoxynojiri
Approximately 60% of the brain metastasis group, 54% of the non-CNS metastasis group, and 18% of healthy controls showed impaired research consent capacity. Our findings, using a performance-based assessment, are consistent with other research indicating that the research consent process may be overly cumbersome and confusing. This, in turn, may lead to research consent impairment not only in patient groups but also in some healthy adults with intact cognitive ability. Our findings, using a performance-based assessment, are c
Curtir
Comentario
Compartilhar
